Collectively, our results reveal opposing roles of the Lrp5/β-catenin axis in tumor cells and osteocytes; these roles impact the metastatic progression of cancer and potentially provide an explanation for the limited success in targeting this signaling axis in advanced cancers. The gene discussed is LRP5; the disease is cancer.